This inventor holds 2 USPTO granted patents. Top assignee: Schering Corporation. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: The Innovative Contributions of Wanil Wu in Hepatitis C Research
Introduction
Wanil Wu, an accomplished inventor based in Edison, NJ, has made significant strides in the field of pharmaceuticals, particularly in the fight against hepatitis C. With two patents to his name, Wu showcases the potential of innovative compounds in medical applications, demonstrating how ingenuity can pave the way for new treatment options.
Latest Patents
Among his notable inventions, Wu has developed compounds that act as inhibitors of the hepatitis C virus NS3 serine protease. These patents disclose novel compounds with HCV protease inhibitory activity, outlining methods for their preparation. Additionally, Wu’s inventions encompass pharmaceutical compositions comprising these compounds, alongside methods for utilizing them in treating disorders related to the HCV protease. This dual focus on both the compounds and their application in medical treatments highlights Wu's commitment to advancing healthcare solutions.
Career Highlights
Wanil Wu is currently associated with Schering Corporation, a firm recognized for its contributions to medications and therapies. His position within this esteemed organization allows him to collaborate with fellow innovators, facilitating the development of groundbreaking medical solutions.
Collaborations
Throughout his career, Wu has had the opportunity to work alongside esteemed colleagues such as Srikanth Venkatraman and F George Njoroge. These collaborations are instrumental in enhancing the research and development process, ultimately leading to more effective treatments for hepatitis C and other health challenges.
Conclusion
In summary, Wanil Wu's contributions to the field of pharmaceutical innovation underscore the importance of collaboration and creativity in addressing complex healthcare issues. His ongoing work at Schering Corporation and his patents illuminate the potential for novel compounds in the fight against hepatitis C, positioning him as a noteworthy inventor in the medical research landscape.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile